Oocyte cryopreservation for fertility-preservation of young woman in cancer and immune disease.

Oocyte cryopreservation for fertility-preservation of young woman in cancer and immune disease. - Oocyte cryopreservation for fertility-preservation

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015212

Enrollment

100

Registered

2014-09-20

Start date

2014-11-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer patient including hematological malignancy, autoimmune disease such as SLE, premature ovarian failure

Interventions

All the members receive the same medical intervention Period (routinely oocyte pick up) Medicational quantity (different among individuals) The number of times (1-2 times of oocyte pick up)

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Survival is anticipated for a long term After the menarche, younger than 42 years

Exclusion criteria

Exclusion criteria: An agreement is not obtained Patient (including age 43 years old or more) who are judged to be inappropriate of this study The patient whom the start of therapy delays for this study

Design outcomes

Primary

Measure	Time frame
Evaluation for a prospective advantage and disadvantage (including complications with the ovarian stimulation)	—

Countries

Japan

Contacts

Public ContactASUKA OKUNOMIYA

Graduate school of medicine, Kyoto University Department of obstetrics and gynecology

okunoask@kuhp.kyoto-u.ac.jp075-751-3269

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026